Vanda Pharmaceuticals Inc.VNDANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-16.25M
↓ 187% below average
Average (9y)
$18.74M
Historical baseline
Range
High:$63.66M
Low:$-16.25M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-16.25M | -230.8% |
| 2023 | $12.42M | -60.3% |
| 2022 | $31.30M | -50.8% |
| 2021 | $63.66M | +27.4% |
| 2020 | $49.98M | +11.2% |
| 2019 | $44.93M | +872.9% |
| 2018 | $4.62M | +226.6% |
| 2017 | $-3.65M | +61.7% |
| 2016 | $-9.51M | -195.8% |
| 2015 | $9.92M | - |